IFNG and Hepatic fibrosis: Encouraging studies revealed a sterically-stabilized liposome (SSL) equipped with the cyclic peptide “C∗SRNLIDC∗ (pPB) with strong binding activity for the PDGF-β receptor (and loaded with IFN-γ) enhanced anti-fibrotic effects of IFN-γ in a murine model of TAA-based hepatic fibrosis (Li et al., 2012).